ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Machine Learning-Driven Design of Multicomponent Bone Inorganic Matrix Mimicking Scaffolds for Osteogenesis Enhanced by Neurogenesis.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Bone defects require materials with osteogenic, neurogenic, and angiogenic activity, yet designing such materials within high-dimensional compositional spaces remains challenging. Here, we report a machine learning (ML) driven strategy to accelerate the design of multicomponent mesoporous bioactive glasses (MBG). A dataset of 169 formulations was used to train a Support Vector Machine (SVM) model to classify osteogenic potential into two classes, high (relative ALP activity ≥0.83) and low (relative ALP activity <0.83). The model screened 10 000 candidates and identified 126 as high potential. These 126 candidates were then subjected to experimental mineralization assays using BMSCs, and selected four high-performance candidates (Candidates 2-5) and one lower-performance control (Candidate 1). The corresponding MBG cores (MBG1-MBG5) were incorporated into NGF-loaded silk fibroin shells to fabricate core-shell nanofibrous scaffolds via coaxial electrospinning. Among them, MBG5@SF/NGF exhibited the highest osteogenic activity, promoting BMSCs viability, differentiation, matrix mineralization, and Erk1/2 phosphorylation, along with upregulation of osteogenic and neuro-inductive markers. Transcriptomic sequencing confirmed activation of osteogenic and neurogenic pathways. In mice calvarial defect model, MBG5@SF/NGF reconstructed a neuro-vascular-bone regenerative microenvironment. We conclude that the ML accelerated screening cascade, combined with experimental validation, identified MBG5@SF/NGF as a promising scaffold for functional bone regeneration.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.